Skip to main content
Signal8

Zura Bio Ltd (ZURA)

Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Zura Bio Limited logo

Zura Bio Limited

NASDAQ:ZURAHealthcare
AH-0.48%$1.03
Close$1.03-4.17%
Mkt Cap$99.7M
EV-
Float68.65M
O/S96.33M
VOL3.52M sh
$ Vol$3.58M
RVOL0.47×
Inst Own71.9%
Net Cash/Sh-
EarningsMar 31 · in 4mo
Dilution
Zura Bio Limited logoNASDAQ:ZURAAH$1.03-0.48%
FormDescription
8-K
8.01,9.01
EFFECT
Notice of Effectiveness
S-3
8-K
10-Q
S-8
SEC Filing
144
Notice of Proposed Sale of Securities
144
Notice of Proposed Sale of Securities
8-K
7.01,9.01
144
Notice of Proposed Sale of Securities
144
Notice of Proposed Sale of Securities
8-K
10-Q
8-K
7.01,9.01
3
Initial Statement of Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
8-K
DEFA14A
Additional Proxy Materials
8-K

1-25 of 447

…

Recent SEC filings with analysis

    Zura Bio Ltd (ZURA) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8